Advertisement
Screener

Cumberland Pharmaceuticals Inc. (CPIX) EBITDA

Cumberland Pharmaceuticals Inc. (CPIX) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$4.37M*; Operating income -$3.16M; Depreciation and amortization -$1.20M*.
  • 2026-03-31: Basis Reported; EBITDA -$1.85M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$329,307.00; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $1.06M*; Operating income -$1.97M; Depreciation and amortization $3.03M*.

Complete source-backed ebitda history.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$4.37M*-$3.16M-$1.20M*$8.80M-49.60%*$38.28K*$168.74K*(m)$772.16K(m)$3.87K
2026-03-31Reported-$1.85M(m)(m)(m)-20.29%$0.00$387.02K$1.93M$1.46M(m)$3.87K
2025-12-31Reported-$329,307.00(m)(m)(m)-2.41%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$1.06M*-$1.97M$3.03M*$8.29M12.79%*$23.79K*$187.18K*$988.76K$1.25M(m)$5.67K
2025-06-30Reported-$4.07M*-$3.12M-$953.82K*$10.84M-37.59%*$26.49K*$843.80K*$2.01M$837.40K(m)$5.67K
2025-03-31Reported$2.32M(m)(m)(m)19.84%$47.63K$3.90M$1.43M$1.30M(m)$5.67K
2024-12-31Reported-$345,645.00(m)(m)(m)-3.31%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$578.40K*-$1.69M$1.12M*$9.09M-6.37%*$15.38K*$475.50K*$1.32M$1.31M(m)$11.44K
2024-06-30Reported$112.76K*-$1.03M$1.14M*$9.85M1.14%*$7.18K*-$855.66K*$1.71M$1.06M(m)$11.44K
2024-03-31Reported-$718,565.00(m)(m)(m)-8.46%$41.62K-$2.14M$1.58M$1.16M(m)$11.44K
2023-12-31Reported-$4.95M(m)(m)(m)-52.88%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$620.51K*-$1.87M$1.25M*$10.09M-6.15%*$53.14K*$1.24M*$1.77M$1.92M(m)$6.94K
2023-06-30Reported$1.22M*$22.86K$1.20M*$10.89M11.24%*$72.19K*$5.24M*$1.52M$1.15M(m)$6.94K
2023-03-31Reported-$276,003.00(m)(m)(m)-2.99%$107.26K-$1.42M$1.25M$1.50M(m)$6.94K
2022-12-31Reported-$1.77M(m)(m)(m)-19.36%(m)(m)(m)(m)(m)(m)
2022-09-30Reported$1.26M*-$288.59K$1.54M*$11.41M11.00%*$91.44K*$2.64M*$2.22M$1.71M(m)$6.90K
2022-06-30Reported-$228.20K*-$1.85M$1.62M*$10.30M-2.22%*$137.25K*$2.33M*$2.03M$1.82M(m)$6.90K
2022-03-31Reported$361,747.00(m)(m)(m)3.24%$26.99K-$150.50K$2.21M$1.75M(m)$6.90K
2021-12-31Reported-$3.28M(m)(m)(m)-44.40%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$489.73K*-$1.56M$1.07M*$8.07M-6.07%*$59.95K*-$102.01K*$1.33M$1.45M(m)$7.46K
2021-06-30Reported-$207.76K*-$1.44M$1.23M*$9.06M-2.29%*$15.07K*$2.70M*$1.74M$1.36M(m)$7.46K
2021-03-31Reported$903,307.00(m)(m)(m)8.57%$19.46K$1.79M$2.42M$1.26M(m)$7.46K
2020-12-31Reported-$522,065.00(m)(m)(m)-6.03%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$18.67K*-$1.21M$1.19M*$9.25M-0.20%*$44.31K*$857.07K*$2.14M$1.23M(m)$3.73K
2020-06-30Reported-$398.36K*-$1.58M$1.18M*$9.60M-4.15%*$28.16K*$2.82M*$2.61M$1.42M(m)$7.46K
2020-03-31Reported-$693,939.00(m)(m)(m)-8.33%$22.73K$888.54K$1.63M$1.72M(m)$34.24K
2019-12-31Reported-$2.27M(m)(m)(m)-30.98%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$2.09M*-$3.20M$1.10M*$6.94M-30.16%*$77.34K*$734.43K*$1.58M$1.67M(m)$4.46K
2019-06-30Reported-$275.27K*-$1.37M$1.10M*$9.42M-2.92%*$61.60K*$1.85M*$1.79M$1.72M(m)$4.46K
2019-03-31Reported-$247,686.00(m)(m)(m)-2.84%$27.47K-$385.73K$1.66M$1.40M(m)-$81.43K
2018-12-31Reported-$5.17M(m)(m)(m)-331.41%(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$1.93M*-$2.64M$713.32K*$8.49M-22.74%*$40.05K*-$1.64M*$1.46M$1.31M(m)$4.16K
2018-06-30Reported-$1.22M*-$1.92M$701.74K*$10.16M-11.98%*$36.80K*$794.09K*$1.52M$1.45M(m)$4.16K
2018-03-31Reported-$1.76M(m)(m)(m)-20.49%$94.88K$235.59K$1.53M$1.87M(m)$4.16K
2017-12-31Reported-$229,767.00(m)(m)(m)-2.11%(m)(m)(m)(m)(m)(m)
2017-09-30Reported-$179.45K*-$839.35K$659.90K*$11.20M-1.60%*$29.75K*$992.84K*$2.17M$943.16K(m)$3.82K
2017-06-30Reported-$1.03M*-$1.68M$652.81K*(m)(m)$19.20K*-$2.53M*(m)$1.08M(m)$3.54M
2017-03-31Reported$3,683.00(m)(m)(m)0.04%$123.94K$1.44M(m)$898.36K(m)-$656.59K
2016-12-31Reported-$345,520.00(m)(m)(m)-4.05%(m)(m)(m)(m)(m)(m)
2016-09-30Reported$743.75K*$130.13K$613.62K*(m)(m)$27.82K*$293.62K*(m)$644.66K(m)$57.19K
2016-06-30Reported$484.04K*-$105.31K$589.34K*(m)(m)-$2.60K*-$1.14M*(m)$678.78K(m)-$41.13K
2016-03-31Reported$81,510.00(m)(m)(m)1.05%$73.06K$598.49K(m)$706.47K(m)-$175.34K
2015-12-31Reported$731,582.00(m)(m)(m)9.10%(m)(m)(m)(m)(m)(m)
2015-09-30Reported$805.79K*$270.88K$534.90K*(m)(m)$34.48K*$485.63K*(m)$757.44K(m)$193.44K
2015-06-30Reported$1.26M*$673.93K$581.75K*(m)(m)-$46.37K*$2.03M*(m)$828.07K(m)$318.99K
2015-03-31Reported$565,364.00(m)(m)(m)6.51%$108.66K$2.03M(m)$1.86M(m)$18.46K
2014-12-31Reported$1.55M(m)(m)(m)16.64%(m)(m)(m)(m)(m)(m)
2014-09-30Reported$1.57M*$989.04K$583.38K*(m)(m)$102.15K*$2.14M*(m)$934.78K(m)$340.98K
2014-06-30Reported$1.62M*$1.22M$405.10K*(m)(m)$18.48K*$835.82K*(m)$861.15K(m)$523.34K
2014-03-31Reported$803,186.00(m)(m)(m)9.92%$29.76K$982.57K(m)$826.37K(m)$188.01K
2013-12-31Reported-$2.09M(m)(m)(m)-25.58%(m)(m)(m)(m)(m)(m)
2013-09-30Reported-$1.21M*-$1.51M$306.96K*(m)(m)$23.32K*-$853.56K*(m)$1.44M(m)-$686.21K
2013-06-30Reported-$821.00K*-$1.14M$319.54K*(m)(m)$8.21K*$121.67K*(m)$1.39M(m)-$463.41K
2013-03-31Reported$1.62M(m)(m)(m)15.76%$60.91K$1.67M(m)$1.45M(m)$559.37K
2012-12-31Reported$3.49M(m)(m)(m)25.48%(m)(m)(m)(m)(m)(m)
2012-09-30Reported$3.20M*$2.98M$223.17K*(m)(m)$114.81K*$1.90M*(m)$1.70M(m)$1.21M
2012-06-30Reported$2.16M*$1.94M$223.94K*(m)(m)$146.09K*$634.81K*(m)$1.55M(m)$263.03K
2012-03-31Reported$863,278.00(m)(m)(m)8.42%$32.80K$2.61M(m)$1.40M(m)$282.03K
2011-12-31Reported$1.95M(m)(m)(m)14.96%(m)(m)(m)(m)(m)(m)
2011-09-30Reported$3.37M*$3.10M$274.18K*(m)(m)$136.05K*$2.76M*(m)$1.23M(m)$1.28M
2011-06-30Reported$3.90M*$3.63M$265.00K*(m)(m)$71.58K*$3.95M*(m)$1.03M(m)$1.44M
2011-03-31Reported$1.67M(m)(m)(m)15.66%$34.26K$983.98K(m)$1.01M(m)$523.58K
2010-12-31Reported$2.49M(m)(m)(m)19.45%(m)(m)(m)(m)(m)(m)
2010-09-30Reported$2.70M*$2.44M$260.01K*(m)(m)$184.99K*$277.94K*(m)$1.14M(m)$943.14K
2010-06-30Reported(m)$1.01M(m)(m)(m)(m)(m)(m)$1.03M(m)$374.46K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Rolling(m)-$9.63M*(m)$39.90M*(m)(m)(m)(m)(m)(m)(m)
2026-03-31Rolling(m)-$9.59M*(m)$41.94M*(m)(m)(m)(m)(m)(m)(m)
2025-12-31Reported$1.35M(m)(m)(m)3.04%$97.90K$4.93M$6.67M$5.57M(m)$40.26K
2025-12-31Rolling(m)-$5.16M*(m)$44.52M*(m)(m)(m)(m)(m)(m)(m)
2025-09-30Rolling(m)-$5.63M*(m)$41.28M*(m)(m)(m)(m)(m)(m)(m)
2025-06-30Rolling(m)-$5.36M*(m)$42.07M*(m)(m)(m)(m)(m)(m)(m)
2025-03-31Rolling(m)-$3.27M*(m)$41.08M*(m)(m)(m)(m)(m)(m)(m)
2024-12-31Reported-$1.53M(m)(m)(m)-4.04%$66.46K-$612.19K$6.59M$4.82M(m)-$22.67K
2024-12-31Rolling(m)-$6.43M*(m)$37.87M*(m)(m)(m)(m)(m)(m)(m)
2024-09-30Rolling(m)-$10.77M*(m)$36.79M*(m)(m)(m)(m)(m)(m)(m)
2024-06-30Rolling(m)-$10.94M*(m)$37.79M*(m)(m)(m)(m)(m)(m)(m)
2024-03-31Rolling(m)-$9.89M*(m)$38.83M*(m)(m)(m)(m)(m)(m)(m)
2023-12-31Reported-$4.62M(m)(m)(m)-11.68%$281.27K$6.09M$6.07M$5.83M(m)$45.77K
2023-12-31Rolling(m)-$9.55M*(m)$39.55M*(m)(m)(m)(m)(m)(m)(m)
2023-09-30Rolling(m)-$5.65M*(m)$39.32M*(m)(m)(m)(m)(m)(m)(m)
2023-06-30Rolling(m)-$4.08M*(m)$40.65M*(m)(m)(m)(m)(m)(m)(m)
2023-03-31Rolling(m)-$5.94M*(m)$40.06M*(m)(m)(m)(m)(m)(m)(m)
2022-12-31Reported-$376,816.00(m)(m)(m)-0.90%$102.15K$8.45M$9.12M$6.69M(m)$68.85K
2022-12-31Rolling(m)-$5.70M*(m)$42.01M*(m)(m)(m)(m)(m)(m)(m)
2022-09-30Rolling(m)-$7.78M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-06-30Rolling(m)-$9.06M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31Rolling(m)-$8.65M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31Reported-$3.07M(m)(m)(m)-8.76%$103.53K$6.34M$8.81M$5.68M(m)$34.89K
2021-12-31Rolling(m)-$7.68M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-09-30Rolling(m)-$5.07M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30Rolling(m)-$4.71M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31Rolling(m)-$4.86M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31Reported-$1.63M(m)(m)(m)-4.56%$140.82K$5.42M$8.65M$5.77M(m)$55.90K
2020-12-31Rolling(m)-$6.38M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30Rolling(m)-$8.03M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30Rolling(m)-$10.02M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31Rolling(m)-$9.81M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31Reported-$4.88M(m)(m)(m)-15.07%$246.20K$3.06M$7.42M$6.87M(m)-$79.32K
2019-12-31Rolling(m)-$9.29M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-09-30Rolling(m)-$9.19M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30Rolling(m)-$8.64M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-03-31Rolling(m)-$9.18M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-12-31Reported-$8.19M(m)(m)(m)-28.43%$455.57K$3.11M$6.02M$7.58M(m)$16.64K
2018-12-31Rolling(m)-$11.17M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-09-30Rolling(m)-$8.78M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-06-30Rolling(m)-$6.98M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-03-31Rolling(m)-$6.74M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-12-31Reported-$1.43M(m)(m)(m)-3.55%$275.96K-$557.71K$5.42M$4.25M(m)$4.17M
2017-12-31Rolling(m)-$4.08M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-09-30Rolling(m)-$4.14M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-06-30Rolling(m)-$3.17M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-03-31Rolling(m)-$1.59M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-12-31Reported$963,777.00(m)(m)(m)2.97%$130.87K$569.48K$5.96M$3.19M(m)-$330.92K
2016-12-31Rolling(m)-$1.43M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-09-30Rolling(m)-$313.08K*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-06-30Rolling(m)-$172.33K*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-03-31Rolling(m)$606.91K*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-12-31Reported$3.36M(m)(m)(m)10.02%$142.97K$5.88M(m)$3.85M(m)$575.83K
2015-12-31Rolling(m)$1.11M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-09-30Rolling(m)$1.90M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-06-30Rolling(m)$2.61M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-03-31Rolling(m)$3.15M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-12-31Reported$5.55M(m)(m)(m)15.04%$163.26K$6.69M(m)$3.39M(m)$1.38M
2014-12-31Rolling(m)$3.56M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-09-30Rolling(m)$140.62K*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-06-30Rolling(m)-$2.36M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-03-31Rolling(m)-$4.72M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-12-31Reported-$2.5M(m)(m)(m)-7.80%$97.41K$746.13K(m)$5.62M(m)-$1.52M
2013-12-31Rolling(m)-$3.80M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-09-30Rolling(m)$1.92M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-06-30Rolling(m)$6.42M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-03-31Rolling(m)$9.50M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-12-31Reported$9.72M(m)(m)(m)19.90%$464.89K$7.14M(m)$5.10M(m)$3.24M
2012-12-31Rolling(m)$8.82M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-09-30Rolling(m)$7.28M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-06-30Rolling(m)$7.40M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-03-31Rolling(m)$9.09M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-12-31Reported$10.89M(m)(m)(m)21.29%$257.50K$8.72M(m)$5.03M(m)$4.08M
2011-12-31Rolling(m)$9.85M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-12-31Reported$7.48M(m)(m)(m)16.31%$577.16K$346.66K(m)$4.33M(m)$2.85M
2009-12-31Reported$6.59M(m)(m)(m)15.14%$601.80K$404.97K(m)$4.99M(m)$2.02M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31